[1] 梁晓峰. 2015中国成人烟草调查报告[M]. 北京:人民卫生出版社,2016:5-6. [2] 戴晓,董志君. 2016—2019年慈溪地区40岁以上人群呼吸系统疾病死亡与烟草暴露的相关性分析[J]. 实用预防医学,2021,28(1):15-19. [3] Babizhayev MA, Yegorov YE. Smoking and health: association between telomere length and factors impacting on human disease, quality of life and life span in a large population-based cohort under the effect of smoking duration[J]. Fundam Clin Pharmacol, 2011, 25(4):425-442. [4] 吴艺凌, 韩耀风,陆文茂,等. 我国烟草所致疾病负担研究[J]. 中国卫生经济,2012,31(11):41-43. [5] 张联,周刚,王卫峰. 河南省医务人员吸烟行为相关危险因素分析[J]. 中国慢性病预防与控制,2006,14(1):30-33. [6] Manley M. Clinical interventions in tobacco control[J]. JAMA, 1991, 266(22):3172. [7] Henningfield JE. Improving the diagnosis and treatment of nicotine dependence[J]. JAMA, 1988, 260(11):1613-1613. [8] Tanaka H,Yamato H,Tanaka T,et al. Effectiveness of a low-intensity intra-worksite intervention on smoking cessation in Japanese employees: a three-year intervention trial[J]. J Occup Health, 2006, 48(3):175-182. [9] Cahill K,Moher M,Lancaster T. Workplace interventions for smoking cessation[J]. Cochrane Database SystRev, 2008(4):CD003440. [10] Fiore MC,Baker T,Jaen CR,et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline[J]. Respir Care, 2008, 45(10):1196-1199. [11] Simmons VN,Litvin EB,Unrod M,et al. Oncology healthcare providers' implementation of the 5A's model of brief intervention for smoking cessation: patients' perceptions[J]. Patient Educ Couns, 2012, 86(3):414-419. [12] World Health Organization. Toolkit for delivering the 5A's and 5R's brief tobacco interventions in primary care[R]. Geneva: WHO, 2014:1-35. [13] 王景红,孙业桓,阚晓宏.应用5A和5R策略对肺结核门诊患者进行戒烟干预的实施效果分析[J].安徽医学,2014,35(3):377-380. [14] 张晓燕,杨莉,田红梅,等.成都市戒烟门诊随访效果分析[J]. 预防医学情报杂志,2013,29(3):193-196. [15] 王呈章,高立冬,胡世雄,等.湖南省疾控机构在职工作人员吸烟行为现状及影响因素分析[J]. 实用预防医学,2019,26(12):1513-1516. [16] 郭艳梅, 张福全, 燕海英,等. 北京市房山区医务人员控烟干预效果评价[J]. 预防医学情报杂志,2009,25(6):419-421. [17] 粟发沃,甘宇,肖信,等.医务人员控烟能力干预效果评估[J].中国社区医师(医学专业),2011,13(21):310-311.
2021, Vol. 28 
